Bio-Techne Corp. (TECH) PT Raised to $560 at Stifel

August 5, 2021 3:56 PM EDT
Get Alerts TECH Hot Sheet
Price: $537.32 --0%

Rating Summary:
    11 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 1 | New: 22
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Stifel analyst Daniel Arias raised the price target on Bio-Techne Corp. (NASDAQ: TECH) to $560.00 (from $475.00) while maintaining a Buy rating.

The analyst commented, "Bio-Techne posted another strong quarter on the heels of the lab spending rebound and demand for a portfolio that continues to be well-positioned in multiple key areas, which has organic growth finishing at 22%. This is notable in that it is well above peers, but even more so when considering that the company is without a major covid testing/vaccine tailwind. Going forward, mgmt seems intent on remaining mostly guidance-free, which leaves the door open to a fairly wide range of potential organic growth outcomes. We have taken our '22 estimate to 16% from 18% (Street 15%) on prudence to start the new fiscal year - but we believe we'll be back at the 17-18% level by the end of the year. We continue to believe TECH is built and set up to deliver multiple years of mid/high-teens growth."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities